acute GI pt 1 Flashcards
esophageal cancer RF, s/s, dx, treatment
smoking & ETOH
dysphagia
EGD w biopsy
tx depends on stage - surgery, chemotherapy, radiation, brachytherapy/stenting
gastric cancer RF, s/s, dx
M>W, pernicious anemia
most asymptomatic
EGD w biopsy, CT for mets
gastric cancer treatment
depends on staging - surgery, chemo, radiation
Herceptin (humanized monoclonal antibody) for metastatic cancer w HER2/neu over expression
Keytruda - for unresectable/metastatic tumors with MSI-H or dMMR
added to chemo typically
pancreatic cancer s/s, dx, tx
most asymptomatic at dx
abd US, CT, ERCP/MRCP
tx depends on staging - Whipple, Traverso-Longmire procedure
pancreas resection, need pancreatic enzyme replacement !
pancreatic cancer biomarker
CA 19-9
used to monitor treatment
hepatocellular carcinoma RF, s/s, dx
cirrhosis (85%), hep B/C, NAFLD, male
most asymptomatic, late s/s: jaundice, ascites, weight loss, etc.
dx - AFP, liver bx, CT/MRI
recommended liver cancer screening
RUQ US q 6 months
AFP q 6 months
all patients with cirrhosis, fam hx of HCC, males, asians, blacks at risk
HCC dx
CT/MRI, percutaneous liver biopsy
AFP (70% elevated)
HCC treatment
depends on stage
transplantation
surgery (resection, ablation)
chemotherapy
transarterial chemoembolization (TACE)
ulcerative colitis
inflammation of colonic mucosa
Crohn’s disease
transmural inflammation of the GI tract
IBD diagnosis
clinical suspicion & r/o other conditions
rule out Yersinia entercolitica
fecal calprotectin - differentiate IBD vs IBS
UC sigmoid/colonoscopy (unless perf risk!)
Crohn’s - colonoscopy w skip lesions/cobblestone appearance
UC complication
toxic megacolon
UC first line tx
mild to moderate. - mesalamine enema/suppository
severe - (>6 bloody stools/day, systemic s/s) - systemic steroids, PO mesalamine
fulminant (>10 stools daily, toxic megacolon, uncontrolled bleeding) - IV steroids, abx, consider surgery
refractory - immunosuppression/biologics
Crohn’s treatment
mesalamine
IV abx
steroids (PO, IV)
immunosuppression